Last fall, community activists voiced concerns over the roll out of studies on Descovy (TAF/FTC) as pre-exposure prophylaxis (PrEP) without adequately involving community advisors.
Long-acting injectable treatment takes another step closer to being a real-world option for people living with HIV, with new study results presented at IAS 2017.
The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become ava...
Ibalizumab, a drug that works against multi-drug-resistant HIV, is now available via the manufacturer's expanded access program.
What's on the horizon for HIV treatment? Here's a look at the HIV drug pipeline from 2017 to 2021.
You may have heard about the "HIV cure with gene editing in animals" story. Here's some help making sense of the story, including what's true or not, and what to get excited about.